{"filing":{"accession_number":"0001193125-26-343395","cik":"0002123613","ticker":null,"company_name":"Kardigan, Inc.","form":"8-K","filing_date":"2026-08-11","report_date":"2026-08-11","primary_document":"ck0002123613-20260811.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2123613/000119312526343395/ck0002123613-20260811.htm"},"events":[{"id":26829,"run_id":24400,"accession_number":"0001193125-26-343395","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"This is a clear earnings release disclosing Kardigan's financial results for the fiscal quarter ended June 30, 2026. The Item 2.02 filing includes a press release (Exhibit 99.1) announcing second quarter 2026 financial results with detailed operating expenses, net loss ($116.2 million), cash position ($660.7 million), and per-share metrics. The disclosure is material to investors as it provides the company's quarterly financial performance and cash runway guidance through multiple clinical milestones.","company_name":"Kardigan, Inc.","ticker":null,"filing_date":"2026-08-11","form":"8-K","submitted_at":null,"items":[{"id":28099,"accession_number":"0001193125-26-343395","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release disclosing Kardigan's financial results for the fiscal quarter ended June 30, 2026. The Item 2.02 filing includes a press release (Exhibit 99.1) announcing second quarter 2026 financial results with detailed operating expenses, net loss ($116.2 million), cash position ($660.7 million), and per-share metrics. The disclosure is material to investors as it provides the company's quarterly financial performance and cash runway guidance through multiple clinical milestones.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-11T11:01:53.717872+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":28099,"accession_number":"0001193125-26-343395","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release disclosing Kardigan's financial results for the fiscal quarter ended June 30, 2026. The Item 2.02 filing includes a press release (Exhibit 99.1) announcing second quarter 2026 financial results with detailed operating expenses, net loss ($116.2 million), cash position ($660.7 million), and per-share metrics. The disclosure is material to investors as it provides the company's quarterly financial performance and cash runway guidance through multiple clinical milestones.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-11T11:01:53.717872+00:00","company_name":"Kardigan, Inc.","ticker":null,"filing_date":"2026-08-11"}]}